Evidence map›Paper›PMID 39897276›Full record

ArticleCureus2025

Role of Dardarin and Isthmin-1 in the Protective Effect of Hydroxytyrosol Against Corn Syrup-Induced Liver Damage.

Elif Onat, Nevin Kocaman, Serhat Hançer, Murat Yildirim

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elif OnatDepartment of Medical Pharmacology, Fırat University, Elazığ, TUR.
Nevin KocamanDepartment of Histology and Embryology, Fırat University, Elazığ, TUR.
Serhat HançerDepartment of Histology and Embryology, Fırat University, Elazığ, TUR.
Murat YildirimDepartment of Pediatrics, University of Wisconsin-Madison, Madison, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn this study, it was investigated whether dardarin (LRRK2) and isthmin-1 (ISM1) play a role in the protective effect of hydroxytyrosol (HT) used to prevent liver damage caused by corn syrup in rats.

methodsRats were divided into four groups with six in each group: 1) control, 2) HT, 3) corn syrup, and 4) corn syrup + HT. Rats were given water containing 30% corn syrup for six weeks. At the same time, HT-containing liquid was given orally at 4 ml/kg/day, alone and together with corn syrup for six weeks. The weights of the rats were measured every week. LRRK2 and ISM1 molecules in liver tissue were evaluated by histopathological methods. Biochemical parameters were also examined with the enzyme-linked immunosorbent assay (ELISA) method.

resultsIt was found that weight gain was less in rats receiving HT than in those consuming corn syrup. The increase in cholesterol, triglyceride, and liver enzyme levels because of corn syrup consumption decreased with HT consumption. As a result of histopathological analysis, it was observed that the increase in LRRK2 and ISM1 levels observed in the liver tissue in the corn syrup-administered group decreased when HT was administered together with corn syrup. In addition, it was determined that the increase in sinusoidal expansion and hepatocyte necrosis observed in the liver tissue as a result of corn syrup application decreased as a result of the application of HT together with corn syrup.

conclusionThe protective effect of HT against the damage caused by corn syrup in the liver has been demonstrated once again; however, LRRK2 and ISM1 are thought to contribute to this issue.

Indexed as

corn syrupdardarinhydroxytyrosolisthmin-1liver

Identifiers

PMID39897276
PMCPMC11787043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.